SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001104659-23-040277
Filing Date
2023-03-31
Accepted
2023-03-31 17:00:09
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-03-31

Document Format Files

Seq Description Document Type Size
1 NT 10-K tm231155d2_nt10k.htm NT 10-K 25114
  Complete submission text file 0001104659-23-040277.txt   26244
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Filer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 001-39788 | Film No.: 23788901
SIC: 2834 Pharmaceutical Preparations